Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Moosig

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Magma (New York, N.Y.)|October 23, 2012
Magnetic resonance imaging in patients with granulomatosis with polyangiitis (Wegener's) and subglottic stenosisThorsten Klink, Julia Holle, Martin Laudien, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2016
Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral CenterJan H Schirmer, Marvin N Wright, Kristine Herrmann, et al.
Annals of the Rheumatic Diseases|August 3, 2016
Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassaysJan Damoiseaux, Elena Csernok, Niels Rasmussen, et al.
Annals of the Rheumatic Diseases|June 1, 2010
Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?Julia U Holle, Wolfgang L Gross, Konstanze Holl-Ulrich, et al.
Clinical and Experimental Rheumatology|April 8, 2011
Distinct proteinase 3-induced cytokine patterns in Wegener´s granulomatosis, Churg-Strauss syndrome, and healthy controlsUrsula Fagin, Elena Csernok, Antje Müller, et al.
Frontiers in Medicine|January 26, 2023
COVID-19 pandemic impairs medical care of vasculitis patients in Germany: Results of a national patient surveyAnna Kernder, Tim Filla, Kirsten de Groot, et al.
Annals of the Rheumatic Diseases|August 14, 2012
A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patientsFrank Moosig, Jan Phillip Bremer, Bernhard Hellmich, et al.
Rheumatology (Oxford, England)|February 27, 2010
Contrasting association of a non-synonymous leptin receptor gene polymorphism with Wegener's granulomatosis and Churg-Strauss syndromeStefan Wieczorek, Julia U Holle, Jan P Bremer, et al.
Arthritis and Rheumatism|July 30, 2010
CCL17/thymus and activation-related chemokine in Churg-Strauss syndromeTomáš Dallos, Gisela Ruiz Heiland, Johanna Strehl, et al.
Clinical and Experimental Rheumatology|July 15, 2020
ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritisChristof Specker, Annette Alberding, Martin Aringer, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Magma (New York, N.Y.)|October 23, 2012
Magnetic resonance imaging in patients with granulomatosis with polyangiitis (Wegener's) and subglottic stenosisThorsten Klink, Julia Holle, Martin Laudien, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2016
Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral CenterJan H Schirmer, Marvin N Wright, Kristine Herrmann, et al.
Annals of the Rheumatic Diseases|August 3, 2016
Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassaysJan Damoiseaux, Elena Csernok, Niels Rasmussen, et al.
Annals of the Rheumatic Diseases|June 1, 2010
Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?Julia U Holle, Wolfgang L Gross, Konstanze Holl-Ulrich, et al.
Clinical and Experimental Rheumatology|April 8, 2011
Distinct proteinase 3-induced cytokine patterns in Wegener´s granulomatosis, Churg-Strauss syndrome, and healthy controlsUrsula Fagin, Elena Csernok, Antje Müller, et al.
Frontiers in Medicine|January 26, 2023
COVID-19 pandemic impairs medical care of vasculitis patients in Germany: Results of a national patient surveyAnna Kernder, Tim Filla, Kirsten de Groot, et al.
Annals of the Rheumatic Diseases|August 14, 2012
A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patientsFrank Moosig, Jan Phillip Bremer, Bernhard Hellmich, et al.
Rheumatology (Oxford, England)|February 27, 2010
Contrasting association of a non-synonymous leptin receptor gene polymorphism with Wegener's granulomatosis and Churg-Strauss syndromeStefan Wieczorek, Julia U Holle, Jan P Bremer, et al.
Arthritis and Rheumatism|July 30, 2010
CCL17/thymus and activation-related chemokine in Churg-Strauss syndromeTomáš Dallos, Gisela Ruiz Heiland, Johanna Strehl, et al.
Clinical and Experimental Rheumatology|July 15, 2020
ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritisChristof Specker, Annette Alberding, Martin Aringer, et al.
Pageof 8